Literature DB >> 26406427

Predicting blood transfusion using automated analysis of pulse oximetry signals and laboratory values.

Stacy Shackelford1, Shiming Yang, Peter Hu, Catriona Miller, Amechi Anazodo, Samuel Galvagno, Yulei Wang, Lauren Hartsky, Raymond Fang, Colin Mackenzie.   

Abstract

BACKGROUND: Identification of hemorrhaging trauma patients and prediction of blood transfusion needs in near real time will expedite care of the critically injured. We hypothesized that automated analysis of pulse oximetry signals in combination with laboratory values and vital signs obtained at the time of triage would predict the need for blood transfusion with accuracy greater than that of triage vital signs or pulse oximetry analysis alone.
METHODS: Continuous pulse oximetry signals were recorded for directly admitted trauma patients with abnormal prehospital shock index (heart rate [HR] / systolic blood pressure) of 0.62 or greater. Predictions of blood transfusion within 24 hours were compared using Delong's method for area under the receiver operating characteristic (AUROC) curves to determine the optimal combination of triage vital signs (prehospital HR + systolic blood pressure), pulse oximetry features (40 waveform features, O2 saturation, HR), and laboratory values (hematocrit, electrolytes, bicarbonate, prothrombin time, international normalization ratio, lactate) in multivariate logistic regression models.
RESULTS: We enrolled 1,191 patients; 339 were excluded because of incomplete data; 40 received blood within 3 hours; and 14 received massive transfusion. Triage vital signs predicted need for transfusion within 3 hours (AUROC, 0.59) and massive transfusion (AUROC, 0.70). Pulse oximetry for 15 minutes predicted transfusion more accurately than triage vital signs for both time frames (3-hour AUROC, 0.74; p = 0.004) (massive transfusion AUROC, 0.88; p < 0.001). An algorithm including triage vital signs, pulse oximetry features, and laboratory values improved accuracy of transfusion prediction (3-hour AUROC, 0.84; p < 0.001) (massive transfusion AUROC, 0.91; p < 0.001).
CONCLUSION: Automated analysis of triage vital signs, 15 minutes of pulse oximetry signals, and laboratory values predicted use of blood transfusion during trauma resuscitation more accurately than triage vital signs or pulse oximetry analysis alone. Results suggest automated calculations from a noninvasive vital sign monitor interfaced with a point-of-care laboratory device may support clinical decisions by recognizing patients with hemorrhage sufficient to need transfusion. LEVEL OF EVIDENCE: Epidemiologic/prognostic study, level III.

Entities:  

Mesh:

Year:  2015        PMID: 26406427     DOI: 10.1097/TA.0000000000000738

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  4 in total

1.  Thrombin Generation Kinetics are Predictive of Rapid Transfusion in Trauma Patients Meeting Critical Administration Threshold.

Authors:  Taleen A MacArthur; Grant M Spears; Rosemary A Kozar; Jing-Fei Dong; Matthew Auton; Donald H Jenkins; Kent R Bailey; Aneel A Ashrani; Mike J Ferrara; Joseph M Immermann; Timothy M Halling; Myung S Park
Journal:  Shock       Date:  2021-03-01       Impact factor: 3.533

Review 2.  Massive transfusion triggers in severe trauma: Scoping review.

Authors:  Cristina Estebaranz-Santamaría; Ana María Palmar-Santos; Azucena Pedraz-Marcos
Journal:  Rev Lat Am Enfermagem       Date:  2018-11-29

3.  Continuous Vital Sign Analysis to Predict Secondary Neurological Decline After Traumatic Brain Injury.

Authors:  Christopher Melinosky; Shiming Yang; Peter Hu; HsiaoChi Li; Catriona H T Miller; Imad Khan; Colin Mackenzie; Wan-Tsu Chang; Gunjan Parikh; Deborah Stein; Neeraj Badjatia
Journal:  Front Neurol       Date:  2018-09-25       Impact factor: 4.003

4.  Prehospital lactate improves prediction of the need for immediate interventions for hemorrhage after trauma.

Authors:  Hiroshi Fukuma; Taka-Aki Nakada; Tadanaga Shimada; Takashi Shimazui; Tuerxun Aizimu; Shota Nakao; Hiroaki Watanabe; Yasuaki Mizushima; Tetsuya Matsuoka
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.